$0.4561
0.02475.73%
Last update: Oct 19, 8:00 AM
$0.4223
-0.0091-2.11%
Biodexa Pharmaceuticals PLC (BDRX) Stock Price, Quote, News & History
BDRXNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Biodexa Pharmaceuticals (NASDAQ:BDRX) through any online brokerage.
Other companies in Biodexa Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Biodexa Pharmaceuticals has a consensus price target of $10000.00.
The stock price for Biodexa Pharmaceuticals (NASDAQ: BDRX) is $0.4223 last updated October 19, 2026 at 8:00 AM EDT.
There are no upcoming dividends for Biodexa Pharmaceuticals.
Biodexa Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Biodexa Pharmaceuticals.
Biodexa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
